The virus that causes COVID-19, SARS-CoV-2, has a large RNA genome that encodes numerous proteins that might be targets for antiviral drugs. Some of these proteins, such as the RNA-dependent RNA polymerase, helicase, and main protease, are well conserved between SARS-CoV-2 and the original SARS virus, but several others are not. This study examines one of the proteins encoded by SARS-CoV-2 that is most different, a macrodomain of nonstructural protein 3 (nsp3). Although 26% of the amino acids in this SARS-CoV-2 macrodomain differ from those observed in other coronaviruses, biochemical and structural data reveal that the protein retains the ability to bind ADP-ribose, which is an important characteristic of beta coronaviruses and a potential...
Viral macrodomains possess the ability to counteract host ADP-ribosylation, a post-translational mod...
Arrival of the novel SARS-CoV-2 has launched a worldwide effort to identify both pre-approved and no...
Arrival of the novel SARS-CoV-2 has launched a worldwide effort to identify both pre-approved and no...
Viral macrodomains have mono-ADP-ribose hydrolytic activity, which can reverse the cellular post-tra...
The SARS-CoV-2 genome encodes for approximately 30 proteins. Within the international project COVID1...
International audienceSARS-CoV-2 is a large, enveloped and positive sense single stranded RNA virus....
The SARS-CoV-2 genome encodes for approximately 30 proteins. Within the international project COVID1...
ADP-ribosylation is a common posttranslational modification that may have antiviral properties and i...
ADP-ribosylation is a common posttranslational modification that may have antiviral properties and i...
ADP-ribosylation is a common posttranslational modification that may have antiviral properties and i...
ADP-ribosylation is a common posttranslational modification that may have antiviral properties and i...
ABSTRACT ADP-ribosylation is a common posttranslational modification that may have antiviral propert...
The nuclear magnetic resonance (NMR) structure of a central segment of the previously annotated seve...
The NMR structure of a central segment of the previously annotated "SARS-unique domain" (SUD-M; "mid...
ABSTRACT The SARS-CoV-2 macrodomain (Mac1) within the non-structural protein 3 (Nsp3) counteracts ho...
Viral macrodomains possess the ability to counteract host ADP-ribosylation, a post-translational mod...
Arrival of the novel SARS-CoV-2 has launched a worldwide effort to identify both pre-approved and no...
Arrival of the novel SARS-CoV-2 has launched a worldwide effort to identify both pre-approved and no...
Viral macrodomains have mono-ADP-ribose hydrolytic activity, which can reverse the cellular post-tra...
The SARS-CoV-2 genome encodes for approximately 30 proteins. Within the international project COVID1...
International audienceSARS-CoV-2 is a large, enveloped and positive sense single stranded RNA virus....
The SARS-CoV-2 genome encodes for approximately 30 proteins. Within the international project COVID1...
ADP-ribosylation is a common posttranslational modification that may have antiviral properties and i...
ADP-ribosylation is a common posttranslational modification that may have antiviral properties and i...
ADP-ribosylation is a common posttranslational modification that may have antiviral properties and i...
ADP-ribosylation is a common posttranslational modification that may have antiviral properties and i...
ABSTRACT ADP-ribosylation is a common posttranslational modification that may have antiviral propert...
The nuclear magnetic resonance (NMR) structure of a central segment of the previously annotated seve...
The NMR structure of a central segment of the previously annotated "SARS-unique domain" (SUD-M; "mid...
ABSTRACT The SARS-CoV-2 macrodomain (Mac1) within the non-structural protein 3 (Nsp3) counteracts ho...
Viral macrodomains possess the ability to counteract host ADP-ribosylation, a post-translational mod...
Arrival of the novel SARS-CoV-2 has launched a worldwide effort to identify both pre-approved and no...
Arrival of the novel SARS-CoV-2 has launched a worldwide effort to identify both pre-approved and no...